Abstract
Non-transferrin bound iron (NTBI) is known to facilitate reactive oxygen species generation which contributes to the development of tissue damage observed in various disorders like hemolytic anemia, hemochromatosis, diabetes mellitus or many forms of neonatal central nervous system damage. Here we are summarizing information about biochemical nature of NTBI and review methods developed for its detection in biological material. Ability to detect NTBI concentration is likely to become an essential tool when it comes to diagnosis of diseases characterized by excessive iron accumulation. In contrast to routinely used parameters such as transferrin saturation or ferritin concentration, NTBI is not affected by inflammatory responses which makes it a reliable indicator. Unfortunately, we are still lacking validated laboratory methods to detect NTBI in biological fluids.
Keywords: Non-transferrin bound iron, Bleomycin, Nitrilotriacetic acid, Desferrioxamine, Hemochromatosis, Clinical Implications, Bacterial siderophore desferrioxamine (DFO), Myelodysplastic syndromes (MDS), Thalassemia
Current Pharmaceutical Analysis
Title: Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications
Volume: 7 Issue: 4
Author(s): Artur Slomka, Katarzyna Piotrowska, Marcin Koba and Ewa Zekanowska
Affiliation:
Keywords: Non-transferrin bound iron, Bleomycin, Nitrilotriacetic acid, Desferrioxamine, Hemochromatosis, Clinical Implications, Bacterial siderophore desferrioxamine (DFO), Myelodysplastic syndromes (MDS), Thalassemia
Abstract: Non-transferrin bound iron (NTBI) is known to facilitate reactive oxygen species generation which contributes to the development of tissue damage observed in various disorders like hemolytic anemia, hemochromatosis, diabetes mellitus or many forms of neonatal central nervous system damage. Here we are summarizing information about biochemical nature of NTBI and review methods developed for its detection in biological material. Ability to detect NTBI concentration is likely to become an essential tool when it comes to diagnosis of diseases characterized by excessive iron accumulation. In contrast to routinely used parameters such as transferrin saturation or ferritin concentration, NTBI is not affected by inflammatory responses which makes it a reliable indicator. Unfortunately, we are still lacking validated laboratory methods to detect NTBI in biological fluids.
Export Options
About this article
Cite this article as:
Slomka Artur, Piotrowska Katarzyna, Koba Marcin and Zekanowska Ewa, Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications, Current Pharmaceutical Analysis 2011; 7 (4) . https://dx.doi.org/10.2174/157341211797458014
DOI https://dx.doi.org/10.2174/157341211797458014 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Signalling Satiety and Starvation to β-Cell Insulin Secretion
Current Diabetes Reviews Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients
Current Drug Safety Development of Novel Glitazones as Antidiabetic Agents: Molecular Design, Synthesis, Evaluation of Glucose Uptake Activity and SAR Studies
Letters in Drug Design & Discovery Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry Cardiovascular disease management through restrained inflammatory responses
Current Pharmaceutical Design The Pleiotropic Effects of Inducible Nitric Oxide Synthase (iNOS) on the Physiology and Pathology of Penile Erection
Current Pharmaceutical Design Immunological Aspects of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Mediators of Low-Grade Chronic Inflammation in Polycystic Ovary Syndrome (PCOS)
Current Pharmaceutical Design The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial: Lipoprotein (a), More than Just Cholesterol?
Current Medicinal Chemistry <i>Ralstonia Mannitolilytica</i>, an Unusual Pathogen in the Neonatal Intensive Care Unit: A Case of Neonatal Sepsis and Literature Review
Infectious Disorders - Drug Targets Biomarkers Linking PCB Exposure and Obesity
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Infectious Disorders - Drug Targets Systemic Oxidative Stress in Older Patients with Mild Cognitive Impairment or Late Onset Alzheimer's Disease
Current Alzheimer Research Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Enterobacteriaceae that Produce Extended-spectrum β -lactamases and AmpC β -lactamases in the Community: The Tip of the Iceberg?
Current Pharmaceutical Design Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism Pharmacogenomics in Psychiatry: Implications for Practice
Recent Patents on Biotechnology Depression in Sleep Related Breathing Disorder
Current Respiratory Medicine Reviews